Ironwood Pharmaceuticals (IRWD) Revenue (2016 - 2025)
Historic Revenue for Ironwood Pharmaceuticals (IRWD) over the last 17 years, with Q3 2025 value amounting to $122.1 million.
- Ironwood Pharmaceuticals' Revenue rose 3326.49% to $122.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $339.0 million, marking a year-over-year decrease of 1042.0%. This contributed to the annual value of $351.4 million for FY2024, which is 2062.75% down from last year.
- Latest data reveals that Ironwood Pharmaceuticals reported Revenue of $122.1 million as of Q3 2025, which was up 3326.49% from $85.2 million recorded in Q2 2025.
- Ironwood Pharmaceuticals' Revenue's 5-year high stood at $122.1 million during Q3 2025, with a 5-year trough of $41.1 million in Q1 2025.
- In the last 5 years, Ironwood Pharmaceuticals' Revenue had a median value of $103.7 million in 2021 and averaged $98.3 million.
- Data for Ironwood Pharmaceuticals' Revenue shows a peak YoY increase of 3326.49% (in 2025) and a maximum YoY decrease of 4505.26% (in 2025) over the last 5 years.
- Ironwood Pharmaceuticals' Revenue (Quarter) stood at $117.1 million in 2021, then dropped by 8.48% to $107.2 million in 2022, then grew by 9.66% to $117.6 million in 2023, then fell by 22.98% to $90.5 million in 2024, then surged by 34.81% to $122.1 million in 2025.
- Its Revenue was $122.1 million in Q3 2025, compared to $85.2 million in Q2 2025 and $41.1 million in Q1 2025.